The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: Are we there yet?

This article is protected by copyright. All rights reserved.
PMID: 29023638 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - October 10, 2017 Category: Dermatology Authors: Geller S, Myskowski PL, Kim YH, Moskowitz A, Horwitz S Tags: Br J Dermatol Source Type: research